Anyone who suffered perforation or required surgery while using a Mirena IUD is urged to speak with a lawyer about their legal options
New York, NY (PRWEB) June 19, 2013
The birth control safety advocates at DrugRisk.com are announcing new information on the site for women using the IUD contraceptive Mirena. A new report shows the FDA has received over 70,000 reports of Mirena side effects, many involving serious injury or requiring surgery*.
DrugRisk was created to improve the safety of patients using popular medication devices like Mirena IUDs by providing the latest safety alerts, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.
The resource center contains warnings from health experts about the risk of perforation from IUDs such as Mirena. The FDA has advised that the procedure of inserting the Mirena IUD can result in perforation of reproductive organs**.
The Journal of the Society of Laparoendoscopic Surgeons also published a study which warns patients that Mirena IUDs can become dislodged and perforate the uterine wall after they are implanted***.
Now, DrugRisk has added a new report which shows the FDA has received 70,072 reports of complications among women using Mirena since 2000, with as many as 6,000 involving device dislocation or perforation of the uterine wall*.
With a growing number of patients filing a Mirena lawsuit, federal cases have been consolidated to a special multi-district litigation court in the Southern District of New York (In Re: Mirena IUD Products Liability Litigation, MDL No. 2434). DrugRisk believes this will expedite the judicial process.
Anyone who suffered perforation or required surgery while using a Mirena IUD is urged to speak with a lawyer about their legal options. However, DrugRisk only recommends lawyers who are already handling Mirena lawsuits.
*NBC News, 6/17/13; nbcnews.com/id/52236628/ns/local_news-cleveland_oh/t/thousands-complaints-about-mirena-iud/#.UcBdwOB6WfQ
**FDA, July 2008; http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm121936.htm
***JSLS March, 2011; ncbi.nlm.nih.gov/pmc/articles/PMC3134688/